Savara Pharmaceuticals
SVRA
#6301
Rank
C$0.85 B
Marketcap
$5.19
Share price
4.72%
Change (1 day)
10.62%
Change (1 year)

EPS for Savara Pharmaceuticals (SVRA)

EPS in 2023 (TTM): -$0.38

According to Savara Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$0.39. In 2022 the company made an earnings per share (EPS) of -$0.34 an increase over its 2021 EPS that were of -$0.47.

EPS history for Savara Pharmaceuticals from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.389.9%
2022-$0.34-26.47%
2021-$0.47-59.52%
2020-$1.16-56.48%
2019-$2.662.66%
2018-$2.59-38.56%
2017-$4.21-71.06%
2016-$14.55-37.06%
2015-$23.124.35%
2014-$22.16-25.81%
2013-$29.86-8.82%
2012-$32.75-27.66%
2011-$45.28-58.41%
2010-$108.86-86%
2009-$777.404.13%
2008-$746.5724%
2007-$602.08-35.9%
2006-$939.2495%
2005-$481.6653.85%
2004-$313.0844.44%
2003-$216.75-40%
2002-$361.25

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$1.38 257.14%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.37-3.57%๐Ÿ‡บ๐Ÿ‡ธ USA